Advances in Molecular Cell Biology of Leukemias
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 36
Special Issue Editors
Interests: chronic lymphocytic leukaemia
Special Issues, Collections and Topics in MDPI journals
Interests: acute myeloid leukemia; chronic lymphocytic leukemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Leukemias are heterogeneous and biologically complex blood malignancies affecting people across entire lifetimes, from childhood to elderly age, with various clinical outcomes.
Over the last decades, dissection of the pathogenetic mechanisms of leukemia, through both classical and very advanced techniques, has brought to light the role of recurrent mutations, epigenetic alterations, and aberrant activation of oncogenic signaling pathways that confer survival advantages to leukemic cells. Understanding leukemogenic mechanisms and tumor cell behavior can allow precision medicine to radically transform diagnostic and therapeutic approaches, thus greatly improving the outcomes of patients with hematological malignancies.
The purpose of this Special Issue is to delve into the continuous expanding field of molecular research on leukemia, in both diagnostic and therapeutic fields, to provide precious translational tools that can help to face yet unmeet clinical needs.
Studies about molecular biomarkers related to pathogenesis, diagnosis, prognosis, new therapeutic opportunities, and treatment resistance of leukemias are welcomed.
Dr. Filomena De Falco
Dr. Daniele Sorcini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- leukemia
- targeted therapies
- signal transduction
- measurable residual disease monitoring
- immunotherapy
